Chemical PA449515

Overview
Prescribing Info
Drug Label Annotations
Clinical Annotations
Variant Annotations
Literature
Pathways
Related To
Links
Navigate to...
Show section selector dropdown

Literature

The publications shown below are associated with this chemical in PharmGKB based on (1) literature annotations, (2) variant annotations, (3) VIP summaries, or (4) pathways.

    31 items
    Literature
    Stevens-Johnson syndrome with overlapping features of DRESS syndrome: A report of two cases.
    SAGE open medical case reports. 2024. Chin Laura D, MacGillivary Michael L, Purdy Kerri S and Kirshen Carly.
    Literature
    Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?
    The pharmacogenomics journal. 2023. Curry Philippa D K, Morris Andrew P, Barton Anne and Bluett James.
    PGx Paper Type: Review
    Literature
    Association between nuclear factor of activated T cells C2 polymorphisms and treatment response in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitors.
    Pharmacogenetics and genomics. 2022. Kim Woorim, Kim Hyun Jeong, Trinh Nga Thi, Yeon Ha Rim, Kim Joo Hee, Choi In Ah, Kim Hyoun-Ah, Jung Ju-Yang and Lee Kyung Eun.
    Literature
    Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-alpha inhibitors and development of machine learning models.
    Scientific reports. 2021. Kim Woorim, Kim Tae Hyeok, Oh Soo Jin, Kim Hyun Jeong, Kim Joo Hee, Kim Hyoun-Ah, Jung Ju-Yang, Choi In Ah and Lee Kyung Eun.
    Literature
    miRNAs as potential biomarkers of treatment outcome in rheumatoid arthritis and ankylosing spondylitis.
    Pharmacogenomics. 2021. Wielinska Joanna and Bogunia-Kubik Katarzyna.
    Literature
    Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity score.
    Pharmacogenomics. 2020. Gilani Syed Sa, Nair Nisha, Plant Darren, Hyrich Kimme, Morgan Ann W, Morris Andrew P, Wilson Anthony G, Isaacs John D, Barton Anne, Bluett James and BRAGGSS Consortium.
    Literature
    Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.
    Nature reviews. Immunology. 2020. Merad Miriam and Martin Jerome C.
    Literature
    Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis.
    Pharmacogenomics. 2017. Ovejero-Benito María C, Prieto-Pérez Rocío, Llamas-Velasco Mar, Belmonte Carmen, Cabaleiro Teresa, Román Manuel, Ochoa Dolores, Talegón María, Saiz-Rodríguez Miriam, Daudén Esteban and Abad-Santos Francisco.
    Literature
    Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.
    The British journal of dermatology. 2017. van den Reek J M P A, Coenen M J H, van de L'Isle Arias M, Zweegers J, Rodijk-Olthuis D, Schalkwijk J, Vermeulen S H, Joosten I, van de Kerkhof P C M, Seyger M M B, Zeeuwen P L J M and de Jong E M G J.
    Literature
    HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients.
    Pharmacogenetics and genomics. 2016. Caldarola Giacomo, Sgambato Alessandro, Fanali Caterina, Moretta Gaia, Farina Marisa, Lucchetti Donatella, Peris Ketty and De Simone Clara.
    Literature
    Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort.
    Pharmacogenomics. 2016. Smith Samantha Louise, Plant Darren, Lee Xiu Hue, Massey Jonathan, Hyrich Kimme, Morgan Ann W, Wilson Anthony G, Isaacs John and Barton Anne.
    Literature
    The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients.
    Pharmacogenetics and genomics. 2015. Batalla Ana, Coto Eliecer, González-Fernández Daniel, González-Lara Leire, Gómez Juan, Santos-Juanes Jorge, Queiro Rubén and Coto-Segura Pablo.
    Literature
    Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response.
    JAMA. 2015. Viatte Sebastien, Plant Darren, Han Buhm, Fu Bo, Yarwood Annie, Thomson Wendy, Symmons Deborah P M, Worthington Jane, Young Adam, Hyrich Kimme L, Morgan Ann W, Wilson Anthony G, Isaacs John D, Raychaudhuri Soumya and Barton Anne.
    Literature
    The polymorphism rs763780 in the IL-17F gene is associated with response to biological drugs in patients with psoriasis.
    Pharmacogenomics. 2015. Prieto-Pérez Rocío, Solano-López Guillermo, Cabaleiro Teresa, Román Manuel, Ochoa Dolores, Talegón María, Baniandrés Ofelia, López Estebaranz José Luis, de la Cueva Pablo, Daudén Esteban and Abad-Santos Francisco.
    Pediatric
    Literature
    Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
    The pharmacogenomics journal. 2014. Bluett J, Ibrahim I, Plant D, Hyrich K L, Morgan A W, Wilson A G, Isaacs J D, BRAGGSS and Barton A.
    Literature
    Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases.
    The pharmacogenomics journal. 2013. Prieto-Pérez R, Cabaleiro T, Daudén E and Abad-Santos F.
    Literature
    Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.
    Clinical reviews in allergy & immunology. 2013. Sivamani Raja K, Goodarzi Heidi, Garcia Miki Shirakawa, Raychaudhuri Siba P, Wehrli Lisa N, Ono Yoko and Maverakis Emanual.
    Literature
    Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.
    Pharmacogenomics. 2013. Umićević Mirkov Maša and Coenen Marieke J H.
    Literature
    Genetic and genomic predictors of anti-TNF response.
    Pharmacogenomics. 2011. Prajapati Rita, Plant Darren and Barton Anne.
    Literature
    Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response.
    Pharmacogenetics and genomics. 2010. Potter Catherine, Gibbons Laura J, Bowes John D, Cordell Heather J, Hyrich Kimme, Isaacs John D, Morgan Ann W, Wilson Anthony G, Barton Anne and Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate.
    Literature
    Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.
    Rheumatology (Oxford, England). 2010. Hassan Batool, Maxwell James R, Hyrich Kimme L, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate, Barton Anne, Worthington Jane, Isaacs John D, Morgan Ann W and Wilson Anthony G.
    Literature
    The TNF superfamily in 2009: new pathways, new indications, and new drugs.
    Drug discovery today. 2009. Tansey Malú G and Szymkowski David E.
    Literature
    Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis.
    The Journal of rheumatology. 2009. Masi Laura, Ricci Laura, Zulian Francesco, Del Monte Francesca, Simonini Gabriele, Capannini Serena, De Martino Maurizio, Brandi Maria Luisa and Falcini Fernanda.
    Pediatric
    Literature
    Perispinal etanercept for neuroinflammatory disorders.
    Drug discovery today. 2009. Tobinick Edward.
    Literature
    Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis.
    Human molecular genetics. 2008. Maxwell James R, Potter Catherine, Hyrich Kimme L, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate, Barton Anne, Worthington Jane, Isaacs John D, Morgan Ann W and Wilson Anthony G.
    Literature
    Pharmacogenetics of etanercept in rheumatoid arthritis.
    Pharmacogenomics. 2008. Danila Maria I, Hughes Laura B and Bridges S Louis.
    Literature
    Etanercept treatment for children and adolescents with plaque psoriasis.
    The New England journal of medicine. 2008. Paller Amy S, Siegfried Elaine C, Langley Richard G, Gottlieb Alice B, Pariser David, Landells Ian, Hebert Adelaide A, Eichenfield Lawrence F, Patel Vaishali, Creamer Kara, Jahreis Angelika and Etanercept Pediatric Psoriasis Study Group.
    Pediatric
    Literature
    Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.
    Pharmacogenomics. 2007. Coenen Marieke J H, Toonen Erik J M, Scheffer Hans, Radstake Timothy R D J, Barrera Pilar and Franke Barbara.
    Literature
    Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.
    Drug discovery today. 2007. Kooloos Wouter M, de Jong Dirk J, Huizinga Tom W J and Guchelaar Henk-Jan.
    Literature
    The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.
    Rheumatology (Oxford, England). 2007. Seitz M, Wirthmüller U, Möller B and Villiger P M.
    Literature
    The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
    Arthritis and rheumatism. 2004. Criswell Lindsey A, Lum Raymond F, Turner Kevin N, Woehl Blanche, Zhu Yuanqing, Wang Jinyi, Tiwari Hemant K, Edberg Jeffrey C, Kimberly Robert P, Moreland Larry W, Seldin Michael F and Bridges S Louis.